Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson’s Disease: A Meta-Analysis of 12 Randomized Controlled Trials

By sjmartinez • July 9, 2024

Jaiswal V, Mashkoor Y, Raj N, Rajak K, Jaiswal A, Fonarow GC. Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson's Disease: A Meta-Analysis of 12 Randomized Controlled Trials. Am J Med. 2024 Jul 6:S0002-9343(24)00420-0. doi: 10.1016/j.amjmed.2024.06.030. Epub ahead of print. PMID: 38977148.

Tags: Cardiology/Epi, Dementia, diabetes mellitus, heart failure, Parkinson’s disease, Publications, SGLT2I

Bioelectronic block of stellate ganglia mitigates pacing-induced heterogeneous release of catecholamine and neuropeptide Y in the infarcted pig heart

Vrabec T, Bender S, Chan SA, Cha S, Haridas S, Hanna P, Ajijola OA, Shivkumar K, Smith C, Ardell JL. Bioelectronic block of stellate ganglia[...]

Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable

Tobis JM, Carroll JD. Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable? Circulation. 2024 Nov 19;150(21):1669-1670. doi: 10.1161/CIRCULATIONAHA.124.071851. Epub 2024 Nov 18.[...]

Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Abdel Jawad M, Spertus JA, Ikeaba U, Greene SJ, Fonarow GC, Chiswell K, Chan PS. Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With[...]